TMEM43 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.609400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.818400E-01
Normal-vs-Stage2
4.640600E-01
Normal-vs-Stage3
5.923800E-01
Normal-vs-Stage4
9.044100E-02
Stage1-vs-Stage2
1.445580E-01
Stage1-vs-Stage3
8.008800E-01
Stage1-vs-Stage4
1.907870E-02
Stage2-vs-Stage3
1.605990E-01
Stage2-vs-Stage4
3.031800E-01
Stage3-vs-Stage4
3.650400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.790200E-01
Normal-vs-AfricanAmerican
5.391600E-01
Normal-vs-Asian
8.582200E-01
Caucasian-vs-AfricanAmerican
7.635400E-01
Caucasian-vs-Asian
4.924200E-01
AfricanAmerican-vs-Asian
5.190800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.864600E-01
Normal-vs-Female
5.312600E-01
Male-vs-Female
8.965200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.195000E-01
Normal-vs-Age(41-60Yrs)
2.253000E-01
Normal-vs-Age(61-80Yrs)
7.572400E-01
Normal-vs-Age(81-100Yrs)
5.860200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.783600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.398800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.384400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.704700E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.715800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.856800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.301600E-01
Normal-vs-Daily Drinker
7.244200E-01
Normal-vs-Weekly Drinker
6.371000E-01
Normal-vs-Occasional Drinker
4.661200E-01
Normal-vs-Social Drinker
6.052600E-01
Non Drinker-vs-Daily Drinker
7.819800E-01
Non Drinker-vs-Weekly Drinker
7.523800E-01
Non Drinker-vs-Occasional Drinker
2.526400E-01
Non Drinker-vs-Social Drinker
5.654400E-01
Daily Drinker-vs-Weekly Drinker
9.516800E-01
Daily Drinker-vs-Occasional Drinker
3.905600E-01
Daily Drinker-vs-Social Drinker
7.477200E-01
Weekly Drinker-vs-Occasional Drinker
4.475400E-01
Weekly Drinker-vs-Social Drinker
7.924800E-01
Occasional Drinker-vs-Social Drinker
6.288800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.939400E-01
Normal-vs-Grade 2
2.182100E-02
Normal-vs-Grade 3
6.596300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.23410000000013E-05
Grade 1-vs-Grade 3
8.198200E-04
Grade 1-vs-Grade 4
3.939400E-01
Grade 2-vs-Grade 3
6.766000E-01
Grade 2-vs-Grade 4
2.182100E-02
Grade 3-vs-Grade 4
6.596300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.544800E-01
Normal-vs-NonDiabetic
6.145000E-01
Diabetic-vs-NonDiabetic
8.329200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.259200E-01
Normal-vs-NoPancreatitis
6.285800E-01
Pancreatitis-vs-NoPancreatitis
4.930200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.081600E-01
Normal-vs-N1
4.418600E-01
N0-vs-N1
7.107700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.648400E-01
Normal-vs-TP53-NonMutant
9.850400E-01
TP53-Mutant-vs-TP53-NonMutant
1.780530E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
